Abbott Laboratories
As of , Abbott Laboratories is named as a defendant in 36 federal civil dockets observed by Repleader, most in the District Court, N.D. Illinois; its latest reported revenue was $44.328 billion for the fiscal year ended , per its 10-K 0001628280-26-010185.
Data through . Filings on SEC EDGAR. Sources are listed at the end of this page.
Public. Ticker ABT, NYSE. SEC CIK 0000001800.
Repleader rankings and indexes are computed from public records by a published method. They describe litigation and business activity. They are not legal advice, investment advice, or a recommendation to buy, sell or hold any security. A lawsuit is an allegation, not a finding of liability. They are not a recommendation to use or avoid any product.
- Dockets naming it
- 36
- Annual revenue
- $44.328 billion
- Net income
- $6.524 billion
Dockets and rankings as of UTC; SEC company facts retrieved .
Facts
| Fact | Value | Source | Date |
|---|---|---|---|
| Ticker and exchange | ABT, NYSE | data.sec.gov | |
| SEC CIK | 0000001800 | data.sec.gov | |
| SEC industry code | 2834 Pharmaceutical Preparations | data.sec.gov | |
| Latest annual report | Form 10-K for the period ended 2025-12-31 | sec.gov | |
| Why it is tracked | Numerous lawsuits alleging its preterm infant formula caused necrotizing enterocolitis (NEC), per its FY2025 10-K. | sec.gov |
Identifiers
SEC CIK 0000001800, ticker ABT. Every filing is on the company's EDGAR page.
| Filing and accession number | Filed | Fiscal years ended |
|---|---|---|
| 10-K 0001628280-26-010185 | , , | |
| 10-K 0001628280-25-007110 | , | |
| 10-K 0001628280-24-005348 | , | |
| 10-K 0001628280-23-004026 | , | |
| 10-K 0001104659-22-025141 | , |
Docket numbers of the dockets naming Abbott Laboratories are in the dockets table, each linked to its CourtListener record.
Measured over time
Dockets naming Abbott Laboratories, by month filed
| Month filed | Dockets | Share of the busiest month |
|---|---|---|
| 2 | ||
| 3 | ||
| 4 | ||
| 1 | ||
| 4 | ||
| 3 | ||
| 5 | ||
| 1 | ||
| 5 | ||
| 5 | ||
| 3 |
Derived numbers
Computed from the records above by a published method, labeled modeled. How they are computed.
Momentum score, rank-1.0
Unranked. Insufficient public data: has revenue growth, scale; missing hiring (no verified public job board); product (no legal AI product line in the universe); voice (headline data pending)
| Component | Raw input | Window | Percentile | Weight | Points |
|---|---|---|---|---|---|
| Revenue growth | $44.328 billion vs $41.95 billion +5.7% modeled | latest fiscal year vs prior | 41.7 modeled | 35% modeled | |
| Scale | $44.328 billion | latest fiscal year | 53.1 modeled | 15% modeled | |
| Hiring | no verified public job board | counted within the last month | 20% modeled | ||
| Product | no legal AI product line in the universe | current universe | 15% modeled | ||
| Voice | headline data pending | last ninety days | 15% modeled |
Litigation exposure, lei-1.0
Observed dockets naming this company as a defendant: 36. The matter index these would be weighted by is not published yet, so the exposure shown is this plain count.
Annual figures reported to the SEC
From SEC EDGAR company facts, annual reports only, as last reported. Each value links to its filing. No stock market data is collected or shown.
| Concept | Latest filing | ||||||
|---|---|---|---|---|---|---|---|
Revenue from Contract with Customer, Excluding Assessed Taxus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $44.328 billion | $41.95 billion | $40.109 billion | $43.653 billion | $43.075 billion | $34.608 billion | 10-K |
Net Income (Loss) Attributable to Parentus-gaap:NetIncomeLoss | $6.524 billion | $13.402 billion | $5.723 billion | $6.933 billion | $7.071 billion | $4.495 billion | 10-K |
Assetsus-gaap:Assets | $86.713 billion | $81.414 billion | $73.214 billion | $74.438 billion | $75.196 billion | $72.548 billion | 10-K |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interestus-gaap:ProfitLoss | $7.071 billion | $4.495 billion | 10-K | ||||
Stockholders' Equity Attributable to Parentus-gaap:StockholdersEquity | $52.13 billion | $47.664 billion | $38.603 billion | $36.686 billion | $35.802 billion | $32.784 billion | 10-K |
Litigation reserve
No litigation-specific reserve reported in the SEC data feed for the latest fiscal year. See the annual report. Amounts a company reports under its own tags or by segment are not in this feed, so a blank here does not mean zero.
Dockets naming Abbott Laboratories
| Docket | Case | Court | Case type | Named as | Filed |
|---|---|---|---|---|---|
| 1:26-cv-00213 | Individual plaintiff | District Court, E.D. Missouri | Health Care/Pharmaceutical Personal Injury Product Liability | defendant | |
| 1:26-cv-10968 | Individual plaintiff | District Court, N.D. Illinois | Health Care/Pharmaceutical Personal Injury Product Liability | defendant | |
| 9:26-cv-81076 | Individual plaintiff | District Court, S.D. Florida | Health Care/Pharmaceutical Personal Injury Product Liability | defendant | |
| 1:26-cv-10164 | Individual plaintiff | District Court, N.D. Illinois | Other Personal Injury | defendant | |
| 1:26-cv-09574 | Individual plaintiff | District Court, N.D. Illinois | Personal Injury - Product Liability | defendant | |
| 4:26-cv-03174 | Individual plaintiff | District Court, D. South Carolina | Health Care/Pharmaceutical Personal Injury Product Liability | defendant | |
| 1:26-cv-09028 | Individual plaintiff | District Court, N.D. Illinois | Other Personal Injury | defendant | |
| 8:26-cv-02086 | Individual plaintiff | District Court, M.D. Florida | Personal Injury - Product Liability | defendant | |
| 1:26-cv-08580 | Individual plaintiff | District Court, N.D. Illinois | Other Personal Injury | defendant | |
| 8:26-cv-00247 | Warren v. Abbott Laboratories, Inc. | District Court, D. Nebraska | Tort Product Liability | defendant | |
| 1:26-cv-00264 | Ghosh v. Abbott Laboratories, Inc. | District Court, D. Hawaii | False Claims Act | defendant | |
| 8:26-cv-02004 | Moss v. Abbott Laboratories | District Court, D. Maryland | Tort Product Liability | defendant | |
| 1:26-cv-05356 | Individual plaintiff | District Court, N.D. Illinois | Personal Injury - Product Liability | defendant | |
| 1:26-cv-05322 | Individual plaintiff | District Court, N.D. Illinois | Personal Injury - Product Liability | defendant | |
| 1:26-cv-04555 | Individual plaintiff | District Court, N.D. Illinois | Personal Injury - Product Liability | defendant | |
| 2:26-cv-01555 | Individual plaintiff | District Court, E.D. California | Personal Injury - Product Liability | defendant | |
| 1:26-cv-04172 | Individual plaintiff | District Court, N.D. Illinois | Personal Injury - Product Liability | defendant | |
| 1:26-cv-03562 | Individual plaintiff | District Court, N.D. Illinois | Personal Injury - Product Liability | defendant | |
| 1:26-cv-03404 | Individual plaintiff | District Court, N.D. Illinois | Personal Injury - Product Liability | defendant | |
| 1:26-cv-02857 | Individual plaintiff | District Court, N.D. Illinois | Personal Injury - Product Liability | defendant |
The newest twenty are shown; the monthly table above counts all of them. A docket naming a company records an allegation or a proceeding, not a finding.
Dockets naming it as a defendant, by district
| District | Dockets as defendant |
|---|---|
| District Court, N.D. Illinois | 25 |
| District Court, N.D. California | 2 |
| District Court, D. Hawaii | 1 |
| District Court, D. Maryland | 1 |
| District Court, D. Nebraska | 1 |
Dockets naming it as a defendant, by case type
| Case type | Dockets as defendant |
|---|---|
| Personal Injury - Product Liability | 23 |
| Health Care/Pharmaceutical Personal Injury Product Liability | 6 |
| Tort Product Liability | 3 |
| Other Personal Injury | 3 |
| False Claims Act | 1 |
Timeline
- . Latest annual report: Form 10-K for the period ended 2025-12-31 (sec.gov)
Related companies
Other public companies in the universe with the same reason for being tracked.
Sources
- data.sec.gov
- sec.gov
- sec.gov
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- courtlistener.com
- data.sec.gov
- sec.gov
- sec.gov
- sec.gov
- sec.gov
- sec.gov
How dockets are matched to companies and how every figure is sourced: Methodology.
Publication check: 31 sourced facts, floor 5
| Sourced facts | 31 | needs 5 |
|---|---|---|
| Table rows | 10 | shown |
| Dated records with sources | 1 | shown |
| Primary identifiers (accessions, docket numbers) | 25 | needs 3 |
| Primary-source links | 29 | shown |
| Internal links to published pages | 11 | shown |